Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Updates from ASCO 2025 explored PARP inhibitors, PSA as a prognostic biomarker and the function of ctDNA in personalizing genitourinary most cancers care.On...
Patti McGee is an writer, a therapeutic massage therapist and breast most cancers survivor of 20 years. Atone for all of Patti's blogs right here!After...
Through the 2025 ASCO Annual Assembly, key updates have been shared throughout all of oncology, together with throughout lung most cancers care. These...
Surrounded by love and encouragement, I overcame worry and nervousness to provide myself life-saving injections after being identified with most cancers and a...
